Grandi M - Search Results

1

Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.

Capranico G, Supino R, Binaschi M, Capolongo L, Grandi M, Suarato A, Zunino F. Capranico G, et al. Among authors: grandi m. Mol Pharmacol. 1994 May;45(5):908-15. Mol Pharmacol. 1994. PMID: 8190107

2

[New anthracyclines and multidrug resistance].

Grandi M, Ballinari D, Capolongo L, Pastori A, Ripamonti M, Suarato A, Spreafico F. Grandi M, et al. Haematologica. 1991 Jun;76 Suppl 3:181-3. Haematologica. 1991. PMID: 1752512 Review. Italian. No abstract available.

3

Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR.

Mariani M, Capolongo L, Suarato A, Bargiotti A, Mongelli N, Grandi M, Beck WT. Mariani M, et al. Among authors: grandi m. Invest New Drugs. 1994;12(2):93-7. doi: 10.1007/BF00874437. Invest New Drugs. 1994. PMID: 7860237

4

Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives.

Ripamonti M, Capolongo L, Melegaro G, Gornati C, Bargiotti A, Caruso M, Grandi M, Suarato A. Ripamonti M, et al. Among authors: grandi m. Invest New Drugs. 1996;14(2):139-46. doi: 10.1007/BF00210784. Invest New Drugs. 1996. PMID: 8913834

5

Reversal of multidrug resistance by new dihydropyridines with low calcium antagonist activity.

Capolongo L, Amboldi N, Ballinari D, Cozzi P, Melegaro G, Ripamonti M, Vaghi F, Grandi M. Capolongo L, et al. Among authors: grandi m. Acta Oncol. 1994;33(7):787-91. doi: 10.3109/02841869409083949. Acta Oncol. 1994. PMID: 7993647

6

The antitumor efficacy of cytotoxic drugs is potentiated by treatment with PNU 145156E, a growth-factor-complexing molecule.

Sola F, Capolongo L, Moneta D, Ubezio P, Grandi M. Sola F, et al. Among authors: grandi m. Cancer Chemother Pharmacol. 1999;43(3):241-6. doi: 10.1007/s002800050890. Cancer Chemother Pharmacol. 1999. PMID: 9923555

7

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.

Ripamonti M, Pezzoni G, Pesenti E, Pastori A, Farao M, Bargiotti A, Suarato A, Spreafico F, Grandi M. Ripamonti M, et al. Among authors: grandi m. Br J Cancer. 1992 May;65(5):703-7. doi: 10.1038/bjc.1992.148. Br J Cancer. 1992. PMID: 1586598 Free PMC article.

8

Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).

Ciomei M, Pastori W, Capolongo L, Geroni C, Melegaro G, Pennella G, Grandi M. Ciomei M, et al. Among authors: grandi m. Br J Cancer. 1995 Dec;72(6):1504-8. doi: 10.1038/bjc.1995.537. Br J Cancer. 1995. PMID: 8519667 Free PMC article.

9

Novel anthracycline analogs.

Grandi M, Pezzoni G, Ballinari D, Capolongo L, Suarato A, Bargiotti A, Faiardi D, Spreafico F. Grandi M, et al. Cancer Treat Rev. 1990 Sep;17(2-3):133-8. doi: 10.1016/0305-7372(90)90037-g. Cancer Treat Rev. 1990. PMID: 2272029 Review. No abstract available.

10

Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).

Capolongo L, Melegaro G, Broggini M, Mongelli N, Grandi M. Capolongo L, et al. Among authors: grandi m. Br J Cancer. 1993 Nov;68(5):916-9. doi: 10.1038/bjc.1993.454. Br J Cancer. 1993. PMID: 8105866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters